Elena R. Fumagalli, MD

Istituto Nazionale Tumori
Milano, Lombardia, Italy

Presentation(s):

• Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB

  Friday, November 18, 2022
  10:30 AM – 10:38 AM

• Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS

  Saturday, November 19, 2022
  8:40 AM – 8:48 AM